Researcher.Life Logo

Expert Review of Hematology : Impact Factor & More

eISSN: 1747-4094pISSN: 1747-4086

Aims and Scope of Expert Review of Hematology

Expert Review of Hematology is a MEDLINE-indexed, peer-reviewed, international medical journal publishing review articles and original papers on all aspects of hematology. It is part of the Expert Review series, published by Informa. Less

Key Metrics

CiteScore
4.2
H-Index
49
Impact Factor
< 5
SJR
Q2Hematology
SNIP
0.99
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Review of Hematology

Expert Review of Hematology Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Review of Hematology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Review of Hematology

Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison
  • 2 Sep 2026
  • Expert Review of Hematology
ADAMTS13 activity and clinical outcomes: a targeted literature review in congenital thrombotic thrombocytopenic purpura and other related thrombotic conditions
  • 3 Jul 2026
  • Expert Review of Hematology
The impact of a cancer diagnosis for myeloproliferative neoplasm (MPN) patients.
  • 29 Jun 2026
  • Expert review of hematology
Lessons from warfarin management during the COVID-19 pandemic: from crisis to an opportunity to revolutionize telemedicine for chronic disease care
  • 27 Jun 2026
  • Expert Review of Hematology
Prognostic factors for patients with relapsed or refractory multiple myeloma who are initiating a fourth or later line car T-cell or bispecific antibody therapy: a systematic literature review and meta-analysis
  • 24 Jun 2026
  • Expert Review of Hematology
Polycythemia vera and metabolic syndrome: is the relationship between the two diseases more than we think?
  • 21 Jun 2026
  • Expert Review of Hematology
Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison
  • 2 Sep 2026
  • Expert Review of Hematology
ADAMTS13 activity and clinical outcomes: a targeted literature review in congenital thrombotic thrombocytopenic purpura and other related thrombotic conditions
  • 3 Jul 2026
  • Expert Review of Hematology
The impact of a cancer diagnosis for myeloproliferative neoplasm (MPN) patients.
  • 29 Jun 2026
  • Expert review of hematology
Lessons from warfarin management during the COVID-19 pandemic: from crisis to an opportunity to revolutionize telemedicine for chronic disease care
  • 27 Jun 2026
  • Expert Review of Hematology
Prognostic factors for patients with relapsed or refractory multiple myeloma who are initiating a fourth or later line car T-cell or bispecific antibody therapy: a systematic literature review and meta-analysis
  • 24 Jun 2026
  • Expert Review of Hematology
Polycythemia vera and metabolic syndrome: is the relationship between the two diseases more than we think?
  • 21 Jun 2026
  • Expert Review of Hematology

FAQs on Expert Review of Hematology